GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

JLK 322510.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

3,940

-1.50%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About JLK

Its shares trade on KOSDAQ under the ticker 322510.KQ. It has been listed since 11 December 2019. In the fiscal year to 31 December 2025, it reported revenue of ₩3.34bn and a net loss of ₩13.61bn. At that date it held total assets of ₩74.43bn and shareholders' equity of ₩41.36bn.

JLK, Inc. develops AI based data-driven diagnostic system that detects brain disease. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2019-12-11. The firm develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
11 Dec 2019

Leadership

Pay as last reported

  • Mr. Dong Min KimChief Executive Officer, Director₩644.3m
  • Mr. Wi Seon YooAssistant Managing Director
  • Mr. Hyeong Jun KimInternal Auditor, Non-Executive Director
  • Mr. Won Tae KimDirector
  • Mr. Heon Yeong YooNon-Executive Independent Director
  • Yeong Eun KimIR Contact Officer

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • JLK Inc's AI medical diagnostic systems detect brain diseases accurately in Cheongju, KR.
  • AI quantitative analysis platforms provide precise medical insights for Health Care sector.
  • AI remote platforms support telemedicine services across South Korea effectively.

Weaknesses

  • Limited market presence in North America despite AI industry analysis solutions.
  • Dependence on Cheongju, KR for headquarters and development activities.
  • Narrow focus on Health Care sector without diversification into other industries.

Opportunities

  • Expansion into Information Technology sector with AI industry analysis solutions.
  • Growth in Health Care segment through AI medical diagnostic platforms.
  • Partnerships with Real Estate firms for AI remote platform applications.

Threats

  • Competition from established Health Care companies in KR market.
  • Regulatory changes in Health Care industry affecting AI medical systems.
  • Economic downturns impacting South Korea's Health Care sector investments.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.